You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
SharePoint
Sign In
Follow
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Home
About
CRISM​
OCRINT
Nominated Principal Investigators
Our Team
Events
Research Projects
COVID-19 Research Projects
OPTIMA
Section 56 Consultation
Follow-Up Study of Federal Inmates on Opioid Agonist Treatment in Ontario
Ontario-Based Residential Treatment Environmental Scan
Inequities in Access to Opioid Agonist Treatment (OAT) Take Home Doses (THD)
COVID-19 Vaccine Confidence Among PWUD
Sudbury Supervised Consumption Site Evaluation
BC Decriminalization Policy Evaluation
Nominal Group Technique (NGT) Board
Advisory Board
Evaluation Design and Logic Model
People Who Use Drugs (PWUD) Qualitative Study
Qualitative Police Study
Quantitative Health and Police Data Analyses
Impact on General Public
Health Service Systems
Economic Impacts
Knowledge Validity and Triangulation
Decriminalization Evaluation Publications and Reports
Research Team
Working Groups
PWLE National Working Group
Cannabis Projects
Implementation Science Program
Naloxone Distribution
Presentations
Detoxification and Withdrawal Management
Corrections Projects
Guidance Documents
COVID-19 Rapid Guidance
Opioid Use Disorder
Injectable OAT
Lower Risk Cannabis Use Guidelines
Supervised Consumption Services
Take-home Naloxone Distribution
Alcohol Use Disorder (AUD) Guidelines
Detoxification and Withdrawal Management
Lower-Risk Cannabis Use Guidelines for Psychosis
Demonstration Projects
Currently selected
Asset Mapping of Substance Use Prevention and Intervention Programs and Services
Surviving Opioid Overdose with Naloxone Education and Resuscitation
Northern Ontario Drug Use and Service Needs Assessment (NODUS)
Youth Substance Use Service Provider Study
Identifying Service Needs among PWUD
2023
Beyond Program Outcomes
Casey House Foundation
The Four Pillar Model
2019
Best Practice Document on Harm Reduction Programs for PWUD
Chronic Disease Self-management Experiences among Marginalized PWUD
Impacts of Overdose Study
It Takes a Village
Best Practices in Buprenorphine/Naloxone Initiation in Provincial Correctional Facilities
Integrating Access to Anti-Craving Medications for Adult Women with SUD
Publications and Reports
Academic Journal Articles
Reports
Knowledge Translation Products
Contact Us
Workshops
Update of Evidence-Based Best Practice Recommendations for Harm Reduction Programs that Provide Harm Reduction Equipment to People Who Use Drugs
Page Content
PI and project team
: Strike, C., Wa
tson, T.M, Miskovic, M., & Challacombe, L.
In response to the growing harms from injecting and smoking psychoactive drugs affecting communities across Ontario and Canada, in 2013 and 2015, a cross-regional, multidisciplinary team of researchers, service users, service providers, and policymakers created the first national-level set of Best Practice Recommendations for needle and syringe programs (NSPs) and other harm reduction programs in Canada. The documents featured evidence syntheses and practical service recommendations related to topics such as the distribution and disposal of drug injection and smoking equipment, overdose prevention services, and varied service model options. Extensive knowledge translation activities were undertaken, resulting in high uptake of the recommendations. In recent years, the scientific literature about these harms and related programming has greatly expanded. This project responds to requests from service providers from across Ontario and Canada for an updated set of best practice recommendations, with particular focus on drug use equipment distribution and overdose education. This project will use an adapted version of the narrative synthesis methods used to develop the first set of recommendations to add and modify them. A Canada-wide team of reserchers, service providers, policy makers and people with lived experience have developed, through extensive literature review and synthesis, an updated and comprehensive set of best practice reccomendations. These recommendations, linked below, and updated in 2021, will help service providers develop, redesign and evaluate programs for people who use drugs and who are at risk for HIV, hepatitis C, hepatitis B, and other harms. The document can also be found on the CATIE website in both English and French:
https://www.catie.ca/
best-practice-recommendations-
for-canadian-harm-reduction-
programs
Best Practice Recommendations Report: